Lynestrenol

Jump to navigation Jump to search
Lynestrenol
Clinical data
AHFS/Drugs.comInternational Drug Names
ATC code
Identifiers
CAS Number
PubChem CID
ChemSpider
UNII
KEGG
E number{{#property:P628}}
ECHA InfoCard{{#property:P2566}}Lua error in Module:EditAtWikidata at line 36: attempt to index field 'wikibase' (a nil value).
Chemical and physical data
FormulaC20H28O
Molar mass284.436 g/mol
3D model (JSmol)
  (verify)

WikiDoc Resources for Lynestrenol

Articles

Most recent articles on Lynestrenol

Most cited articles on Lynestrenol

Review articles on Lynestrenol

Articles on Lynestrenol in N Eng J Med, Lancet, BMJ

Media

Powerpoint slides on Lynestrenol

Images of Lynestrenol

Photos of Lynestrenol

Podcasts & MP3s on Lynestrenol

Videos on Lynestrenol

Evidence Based Medicine

Cochrane Collaboration on Lynestrenol

Bandolier on Lynestrenol

TRIP on Lynestrenol

Clinical Trials

Ongoing Trials on Lynestrenol at Clinical Trials.gov

Trial results on Lynestrenol

Clinical Trials on Lynestrenol at Google

Guidelines / Policies / Govt

US National Guidelines Clearinghouse on Lynestrenol

NICE Guidance on Lynestrenol

NHS PRODIGY Guidance

FDA on Lynestrenol

CDC on Lynestrenol

Books

Books on Lynestrenol

News

Lynestrenol in the news

Be alerted to news on Lynestrenol

News trends on Lynestrenol

Commentary

Blogs on Lynestrenol

Definitions

Definitions of Lynestrenol

Patient Resources / Community

Patient resources on Lynestrenol

Discussion groups on Lynestrenol

Patient Handouts on Lynestrenol

Directions to Hospitals Treating Lynestrenol

Risk calculators and risk factors for Lynestrenol

Healthcare Provider Resources

Symptoms of Lynestrenol

Causes & Risk Factors for Lynestrenol

Diagnostic studies for Lynestrenol

Treatment of Lynestrenol

Continuing Medical Education (CME)

CME Programs on Lynestrenol

International

Lynestrenol en Espanol

Lynestrenol en Francais

Business

Lynestrenol in the Marketplace

Patents on Lynestrenol

Experimental / Informatics

List of terms related to Lynestrenol

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]

Overview

Lynestrenol is a progestogen hormone. It is a synthetic orally-available progestagen associated with numerous effects of the natural progesterone hormone. Lynestrenol has a strong progestational effect on the uterine endometrium (transforming proliferative endometrium into secretory one), inhibits secretion of gonadotropin, suppresses maturation of follicles in the ovaries and ovulation, reduces menstrual bleeding. This synthetic gestagen is associated with minimal estrogenic, androgenic and anabolic effects. Lynestrenol is used in treatment of hormonal disorders and diseases caused by insufficient secretion of the natural progesterone, except in case of risky pregnancies and prevention of miscarriage, since it is not efficient enough in this indication.

Pharmacology

After oral administration lynestrenol is quickly resorbed and converted into pharmacologically active norethisterone, through which it demonstrates the main biological effects. The peak blood are reached within 2–4 hours after oral administration, 97% of the administered dose being bound to plasma proteins. Lynestrenol and its metabolites are predominantly excreted in the urine, less through feces, active metabolite norethisterone elimination halftime being 16-17 h.

See also

References